For endometriosis‐associated ovarian carcinomas, we validate that abnormal p53 IHC is a strong independent prognostic marker for EC and demonstrate for the first time an independent prognostic association of abnormal p53 IHC with overall survival in CCC, especially for stage I/II CCC. This evidence concerns the gene TP53 and ovarian carcinoma.